drugset / Trial / NCT02634320
A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the safety and tolerability of aripiprazole lauroxil (also known as ARISTADA, ALKS 9070).
Timeline
- Start
- 2015-12
- Primary completion
- 2017-07-11
- Completion
- 2017-07-11
Outcome
Missed primary endpoint
registry analysis (other test); Aripiprazole Lauroxil; p = 0.078; t-test, 2 sided NCT02634320 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole Lauroxil | Small molecule | 441 mg | Intramuscular |
| Subject | Aripiprazole Lauroxil | Small molecule | 662 mg | Intramuscular |
| Subject | Aripiprazole Lauroxil | Small molecule | 882 mg | Intramuscular |